0.491
price down icon3.88%   -0.0198
after-market 시간 외 거래: .49 -0.001 -0.20%
loading
전일 마감가:
$0.5108
열려 있는:
$0.51
하루 거래량:
680.84K
Relative Volume:
0.12
시가총액:
$8.30M
수익:
-
순이익/손실:
$-14.58M
주가수익비율:
-0.427
EPS:
-1.15
순현금흐름:
$-9.80M
1주 성능:
-21.88%
1개월 성능:
+26.35%
6개월 성능:
-39.68%
1년 성능:
-77.06%
1일 변동 폭
Value
$0.487
$0.5342
1주일 범위
Value
$0.43
$0.63
52주 변동 폭
Value
$0.30
$3.325

Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile

Name
명칭
Acurx Pharmaceuticals Inc
Name
전화
917-533-1469
Name
주소
259 LIBERTY AVENUE, STATEN ISLAND
Name
직원
4
Name
트위터
Name
다음 수익 날짜
2025-03-18
Name
최신 SEC 제출 서류
Name
ACXP's Discussions on Twitter

ACXP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ACXP
Acurx Pharmaceuticals Inc
0.491 8.30M 0 -14.58M -9.80M -1.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Acurx Pharmaceuticals Inc 주식(ACXP)의 최신 뉴스

pulisher
Jun 18, 2025

Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year? - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Investors Purchase Large Volume of Acurx Pharmaceuticals Call Options (NASDAQ:ACXP) - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Acurx Pharmaceuticals Raises Fresh $2.67M Capital: New Antibiotic Development Gets Major Funding Boost - Stock Titan

Jun 17, 2025
pulisher
Jun 17, 2025

/C O R R E C T I O N -- Acurx Pharmaceuticals, Inc./ - Yahoo Finance

Jun 17, 2025
pulisher
Jun 17, 2025

Acurx Pharmaceuticals Inc (ACXP) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Crude Oil Rises Sharply; Jabil Earnings Top Views - Benzinga

Jun 17, 2025
pulisher
Jun 17, 2025

US Stocks Lower; Retail Sales Decline In May - Benzinga

Jun 17, 2025
pulisher
Jun 17, 2025

Power Metallic (TSX.V: PNPN) Secures Largest Saudi License Amid June 2025 Gold Surge – Material Gains & More Stocks Inside - FinancialContent

Jun 17, 2025
pulisher
Jun 17, 2025

Acurx Pharmaceuticals Soars as Breakthrough Antibiotic Data Hits the Headlines - RagingBull

Jun 17, 2025
pulisher
Jun 17, 2025

Banco Santander S.A. ADR Inc. (SAN) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Why Is Acurx Pharmaceuticals Stock (ACXP) Up 250% Today? - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Breakthrough: New Antibiotic Achieves 94% Cure Rate Against C. Difficile, Outperforms Standard Treatment - Stock Titan

Jun 17, 2025
pulisher
Jun 15, 2025

(PDF) A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority pathogens - researchgate.net

Jun 15, 2025
pulisher
Jun 10, 2025

Mirum Pharmaceuticals Expands Team with 10 New Hires, Grants $5.7M Stock Options Package - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

TJX Maintains Strong Dividend Program: Top Retail Chain Announces $0.425 Per Share Payout - Stock Titan

Jun 10, 2025
pulisher
Jun 09, 2025

New to The Street's Documentary Specials Break Records: IMG Academy Surpasses 126,000 Views in Just 12 Days - Akron Beacon Journal

Jun 09, 2025
pulisher
Jun 09, 2025

Acurx announces presentation of results for DNA pol IIIC inhibitors - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC Inhibitors - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Acurx (ACXP) Advances Antibiotic Candidate for C. difficile Treatment | ACXP Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Warner Bros. Discovery to split into two companies, dividing cable and streaming services - WFMZ.com

Jun 09, 2025
pulisher
Jun 09, 2025

Breakthrough: New Antibiotic Class Shows Promise Against Drug-Resistant C. DifficilePhase 3 Ready - Stock Titan

Jun 09, 2025
pulisher
Jun 04, 2025

Clostridium Difficile Infections Pipeline 2025: MOA and ROA - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Popular Inc Delivers Double Income Stream: New Preferred Stock Dividend Plus Trust Securities Distribution - Stock Titan

Jun 03, 2025
pulisher
Jun 02, 2025

Exclusive: Aptar Leadership Team Set for Strategic Updates at Major Investment Conferences - Stock Titan

Jun 02, 2025
pulisher
May 29, 2025

Medical Properties Trust Dividend Alert: $0.08 Per Share Payable July 17Key Dates Inside - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Exicure Faces Nasdaq Delisting Risk: 60 Days to Submit Compliance Plan for Late Q1 Filing - Stock Titan

May 28, 2025
pulisher
May 23, 2025

Ardent Health Partners Streamlines Brand Identity: What the New Corporate Name Means for Investors - Stock Titan

May 23, 2025
pulisher
May 22, 2025

Chikungunya wins boost Valneva; overall infectious disease stocks fall - BioWorld MedTech

May 22, 2025
pulisher
May 21, 2025

ACXP Stock: Selling Stockholder to Offload Shares with No Procee - GuruFocus

May 21, 2025
pulisher
May 21, 2025

ACXP Stock: Selling Stockholder to Offload Shares with No Proceeds to Company | ACXP Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Acurx Pharmaceuticals Inc Files For Resale Of Up To 10.9 Million Shares Of Common Stock By The Selling StockholderSEC Filing - marketscreener.com

May 21, 2025
pulisher
May 19, 2025

Q2 Earnings Forecast for ACXP Issued By HC Wainwright - Defense World

May 19, 2025
pulisher
May 17, 2025

HC Wainwright Reaffirms “Buy” Rating for Acurx Pharmaceuticals (NASDAQ:ACXP) - Defense World

May 17, 2025
pulisher
May 16, 2025

Acurx signals progress in Phase 3 ibezapolstat program with $12M credit line following regulatory alignment - MSN

May 16, 2025
pulisher
May 15, 2025

Acurx Pharmaceuticals’ Earnings Call: Progress Amidst Funding Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

ACXP: Acurx Pharmaceuticals Receives 'Buy' Rating from HC Wainwr - GuruFocus

May 15, 2025
pulisher
May 15, 2025

H.C. Wainwright sets $8 target for Acurx Pharmaceuticals stock - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

H.C. Wainwright Initiates Buy Coverage on Acurx (ACXP) with $8 T - GuruFocus

May 15, 2025
pulisher
May 15, 2025

H.C. Wainwright sets $8 target for Acurx Pharmaceuticals stock By Investing.com - Investing.com India

May 15, 2025
pulisher
May 15, 2025

H.C. Wainwright Initiates Buy Coverage on Acurx (ACXP) with $8 Target | ACXP Stock News - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Acurx Pharmaceuticals Reports Improved Q1 2025 Results - TipRanks

May 14, 2025
pulisher
May 13, 2025

Earnings call transcript: Acurx Pharmaceuticals beats Q1 2025 EPS forecast By Investing.com - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Acurx Pharmaceuticals Q1 Net Income USD -2.1 Million - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update - Stock Titan

May 13, 2025
pulisher
May 12, 2025

Acurx Pharmaceuticals, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Tesla Stock Is Climbing Monday: What's Going On?Tesla (NASDAQ:TSLA) - Benzinga

May 12, 2025
pulisher
May 11, 2025

Acurx Pharmaceuticals (ACXP) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

Acurx Pharmaceuticals Enters $12M Stock Purchase Agreement - TipRanks

May 08, 2025
pulisher
May 07, 2025

Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y - Yahoo Finance

May 07, 2025

Acurx Pharmaceuticals Inc (ACXP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Acurx Pharmaceuticals Inc 주식 (ACXP) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Sailer Carl
Director
Jan 06 '25
Buy
1.01
24,631
25,000
137,183
LUCI DAVID P
President and CEO
Jan 06 '25
Buy
1.01
49,261
50,000
1,097,458
Donohue James J.
Director
Jan 06 '25
Buy
1.01
9,852
10,000
22,352
DELUCCIA ROBERT J
Director
Jan 06 '25
Buy
1.01
49,261
50,000
1,010,196
DEAN JACK H
Director
Jan 06 '25
Buy
1.01
9,852
10,000
21,776
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):